New analysis proposes Severe COVID-19 is a Microvascular Disease
The range of clinical responses to SARS-CoV-2 infection is extremely broad, a factor making the disease particularly difficult to properly
Read more
Respiratory
Corticosteroid Dexamethasone could be a lifeline for COVID-19 patients
The initial Dexamethasone clinical trial outcomes in the UK have demonstrated that the generic corticosteroid medication could present a lifeline
Read more
Reinstated hydroxychloroquine study reveals the dangers of rushed trials
The World Health Organisation (WHO) halted one arm of the hydroxychloroquine COVID-19 Trial at the end of May, only to
Read more
Algernon gets FDA nod for human study of Ifenprodil for COVID-19
Algernon has received the FDA’s approval for the commencement of a Phase 2 and 3 human study of it’s repurposed
Read more
ACTide EDC (Electronic Data Capture) System against COVID-19
Nubilaria, a forward thinking clinical data management company, has released an important announcement for Researchers and Health Professionals in Europe
Read more
Nubilaria provides free EDC for pro bono COVID-19 related ARDS study
Nubilaria is providing it’s innovative ACTide EDC system free in support of a clinical study for COVID-19 related ARDS intensive
Read more
Altasciences completes Gimsilumab Phase I study for ARDS in COVID-19
Canadian Altasciences completes its Phase I study on Gimsilumab to prevent and treat acute respiratory distress syndrome (ARDS) in COVID-19
Read more
EU waiving VAT and customs duty on critical medical devices
The European Commission has waived customs duty and VAT on medical devices imported from non-EU countries. A decision has been
Read more
Roche’s Actemra (tocilizumab) shows “excellent effects” against COVID-19
The widely used arthritis medicine Actemra (tocilizumab) has demonstrated “excellent effects” in the treatment of the COVID-19 disease. Roche’s promising
Read more
Kaletra (lopinavir/ritonavir) disappoints as treatment for severe COVID-19
Kaletra, a medicine containing two HIV drugs, lopinavir and ritonavir, which was considered as a potential treatment for the novel
Read more